Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,609.78
(
0.13%
)
US TECH 100
29,808.40
(
0.33%
)
Dow Jones
51,307.79
(
0.45%
)
Brent Oil
96.18
(
0.96%
)
Bitcoin
66,828.12
(
0.21%
)
News Focus
News Focus
Post# of 828926
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jesster64

Send PM Follow Ignore
Followers 23
Posts 2943
Boards Moderated 0
Alias Born 03/22/2021

jesster64

Re: FeMike post# 776082

Tuesday, 07/15/2025 11:52:40 AM

Tuesday, July 15, 2025 11:52:40 AM

Post# of 828926
Thanks for the response FeMike. I enjoy your posts even though some call them bashing. My point of view is the valuation does not have to be at current market price. If the combo trial with keytruda was as big a success as rumored, couldn't evaluation take into account what projected future sales could be. LP could be using keytuda worldwide sales as a starting point in evaluation?
Also, it would make sense then for why bashers would be trying to bring the value down, but wouldnt that be a stock manipulation violation?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News